2017 Annual Meeting | ��ɫ�� and Publications Station: Amyloid Removal and Cognition in Alzheimer's Disease

Date Friday 04/28/17

Time 01:00 PM - 02:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs

Director(s) George Perry, PhD

Topic(s)

CME Available No CME available

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Event Timeline
01:00 PM - 02:00 PM	Speaker	��ɫ�� and Publications Station: Amyloid Removal and Cognition in Alzheimer's Disease George Perry, PhD

Faculty Disclosures
George Perry, PhD	Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Synaptogenix. Dr. Perry has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE. Dr. Perry has stock in Synaptogenix.

��ɫ����